Characteristics of Patients With Sickle Cell Disease

Clinical trial NCT05494541 · COMPLETED

Trial details

NCT number: NCT05494541
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Sickle Cell Disease

Start date: 2021-08-30
Primary completion: 2021-10-27
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.